posted on 2023-12-21, 18:26authored byHolly C. Simmons, Akiko Watanabe, Thomas H. Oguin III, Elizabeth S. Van Itallie, Kevin J. Wiehe, Gregory D. Sempowski, Masayuki Kuraoka, Garnett Kelsoe, Kevin R. McCarthy
The broadly binding, head interface directed S5V2-29 [22] was used as a positive control and an influenza B specific, RBS directed antibody, CR8033 [25], as a negative control for influenza A isolates. Data points represent the average of 3 technical replicates. The standard error of the mean is shown for each point. KDs were calculated from the curves fit to these data points. Figure data are in S2 Data.